ATHAGORAS
LIVE

Serial Number

79413249

Owner

ATHAGORAS Holding GmbH

Attorney

Deborah J Peckham/

Filing Date

Jul 19, 2024

Add to watchlist:

No watchlists yet
View on USPTO

ATHAGORAS Trademark

Serial Number: 79413249

ATHAGORAS is a trademark filed by ATHAGORAS Holding GmbH on July 19, 2024. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

ATHAGORAS Holding GmbH

Theatinerstraße 14

Entity Type: 27

Trademark Details

Filing Date

July 19, 2024

Registration Date

Not Registered

Published for Opposition

April 21, 2026

Goods & Services

Advertising services; business management; business organization consultancy; business administration; clerical services; marketing services; business management and organization consultancy; business efficiency expert services; business analysis and information services, and market research; assistance in business matters, namely, commercial assistance in business management, and assistance in business administrative services in the nature of business appraisals and evaluations of businesses in the fields of medicine, pharmaceuticals, medical practice, medical devices and medical diagnostics; business inquiries; business assistance, namely, assistance with business management, business planning and business consultancy relating to regulatory compliance; business administrative services; business networking, namely, arranging of business introductions; planning and organising trade fairs, exhibitions and presentations for business purposes in the nature of initiating business contacts and cooperations

Scientific and technological services and research and design relating thereto, namely, research and development in the field of pharmaceutical products, medical devices, medical diagnostics and pharmaceuticals; industrial analysis, namely, scientific research and technological research in the fields of medical devices and pharmaceuticals, testing, analysis and evaluation of medical research data and health research data, and data analysis being scientific and technological research in the fields of health, wellness, medical devices, medical diagnostics and pharmaceuticals; quality control for others and authentication services being the authentication of medical and pharmaceutical research data, and research and development of new products for others; providing information on medical and scientific research; testing, inspection and research services in the field of pharmaceuticals; medical and pharmacological research services; technical consultancy services in relation to quality management, quality control and quality protection in the fields of medical devices, medical technologies and pharmaceuticals; pharmaceutical testing, namely, conducting technical tests in relation to pharmaceutical products, medical products and pharmaceuticals; product quality testing, namely, quality testing of pharmaceutical products, medical products and pharmaceuticals; product safety testing; quality control for others; consulting services in the fields of pharmaceutical research, medical technology, and medical devices namely, technological and scientific advice relating to ensuring the safety of pharmaceutical products, medical products and pharmaceuticals; consulting services in the field of pharmaceutical research, namely, technological and scientific advice in relation to the development and authorisation processes for pharmaceutical products, medical products and pharmaceuticals, chemical samples and biological samples

Medical services; beauty care services, namely, providing human hygiene and beauty care; pharmacy advice, namely, pharmaceutical advice; medicine information services, professional consultancy in the field of medical technology in the nature of consulting in the fields of medical care, diagnostic medical testing and clinical medical practice and providing medical information relating to diagnostics; medical screening; pharmaceutical consultancy services, providing medical information in the field of pharmacological treatment, medical services and medical diagnostic services related to the field of drug safety; provision of medical counselling and information services relating to pharmacovigilance

Legal services; security guard services for the physical protection of individuals; legal advisory services, namely, advisory services relating to regulatory affairs; regulatory compliance auditing; legal advice on regulatory matters and in connection with the authorisation of pharmaceutical preparations

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 25, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 25, 2026 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 21, 2026 NPUB
PUBLISHED FOR OPPOSITION
Apr 21, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 15, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 24, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 24, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 23, 2026 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Mar 23, 2026 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Sep 29, 2025 GNFN
FINAL REFUSAL E-MAILED
Sep 29, 2025 GNFR
FINAL REFUSAL WRITTEN
Sep 29, 2025 CNFR
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Aug 29, 2025 AMPX
TEAS VOLUNTARY AMENDMENT RECEIVED
Aug 29, 2025 PARI
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 27, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 27, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 27, 2025 TROA
REFUSAL PROCESSED BY IB
Mar 22, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 6, 2025 RFCS
REFUSAL PROCESSED BY MPU
Mar 6, 2025 RFRR
NEW REPRESENTATIVE AT IB RECEIVED
Jan 31, 2025 NREP
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 20, 2025 RFCR
NON-FINAL ACTION WRITTEN
Jan 19, 2025 CNRT
ASSIGNED TO EXAMINER
Jan 7, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 27, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 27, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 26, 2024 REPR